This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Institut Pasteur. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Frederic Dessauge: Innovator in Antitumoral and Antiviral Peptides
Introduction
Frederic Dessauge is a notable inventor based in Paris, France. He has made significant contributions to the field of biochemistry, particularly in the development of peptides that have potential applications in antitumoral, antiviral, and antiparasitic treatments. His innovative work has garnered attention in the scientific community.
Latest Patents
Frederic Dessauge holds a patent for "Peptides binding to the phosphatase 2A protein." This invention relates to novel synthetic or natural E4orf4 or Bcl-2 peptides that are particularly useful in various medical treatments. The peptides are less than 30 amino acids long and are designed to bind in vitro to a phosphatase 2A protein holoenzyme or one of its subunits. The patent also encompasses polynucleotides encoding these novel peptides, vectors expressing them, as well as antibodies and probes that identify the transcripts.
Career Highlights
Dessauge is affiliated with the prestigious Institut Pasteur, where he continues to advance research in his field. His work is characterized by a commitment to innovation and the application of scientific knowledge to real-world health challenges.
Collaborations
Frederic Dessauge collaborates with esteemed colleagues such as Alphonse Garcia and Angelita Rebollo. These partnerships enhance the research environment and contribute to the development of groundbreaking solutions in biomedicine.
Conclusion
Frederic Dessauge's contributions to the field of peptide research exemplify the intersection of innovation and healthcare. His work not only advances scientific understanding but also holds promise for future therapeutic applications.